481 - 492 of 7718 results

FAQ for What's New in Obesity Management?

Guest: Robert F. Kushner, MD, FACP


0.51 CME CREDIT

Did you know that approximately two-thirds of adults with severe asthma are eosinophilic? The presence of eosinophilia can have implications for asthma management as well. Join Dr. Nicola Hanania, pulmonologist and asthma expert, as he reviews the case of a patient with severe asthma and discusses how primary care clinicians can identify eosinophilia, using common biomarkers, and improve outcomes in patients with eosinophilic asthma.


FAQ for Re-Engineering Your Clinical Practice for the Patient and Clinician Well-Being

Among physicians and other healthcare practitioners, burnout has reached epidemic proportions. Many physicians feel overworked and frustrated. This session will be designed to offer tips so that you can work more efficiently and get home earlier from your day. The goal of this session is not just to avoid burnout, but to give you at least a few tools to use every day in your practice that will move you closer to thriving at work. While being mindful of practice resource constraints, we will discuss being more efficient with your EMR, utilizing your team to respond to messages, streamlining the refill process and reducing the frustrations from difficult patients. Guest: Jay Winner, MD, FAAFP

Among physicians and other healthcare practitioners, burnout has reached epidemic proportions. Many physicians feel overworked and frustrated. This session will be designed to offer tips so that you can work more efficiently and get home earlier from your day. The goal of this session is not just to avoid burnout, but to give you at least a few tools to use every day in your practice that will move you closer to thriving at work. While being mindful of practice resource constraints, we will discuss being more efficient with your EMR, utilizing your team to respond to messages, streamlining the refill process and reducing the frustrations from difficult patients.


Mortality of CRM Disorders: The Benefits of a Collaborative Care Approach

Industry Podcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit

During this podcast, expert pulmonologists who specialize in the field of interstitial lung disease (ILD) focus on recognizing and referring patients with signs of potential idiopathic pulmonary fibrosis For more interstitial lung disease (ILD) educational content, please visit www.InsightsinILD.com


FAQ for e-Cigarettes and Vaping: The Good, the Bad, and the Ugly

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping.Guest: Susan Feeney, DNP, FNP-BC, NP-C

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping.


FAQ for Fad Diets: Keto, Elimination, and More

Guest: Bethany Doerfler, MS, RDN


FAQ for GAIT: An Eyeblink Diagnosis

Guest: Salvatore Mangione, MD

Mobility disorders are a menace of old age, often resulting in falls, injuries, and especially hip fractures -- the sixth leading cause of death in the elderly. Primary care physicians have difficulties in both detecting and correctly identifying these abnormalities. In a paper published in the Journal of the American Geriatrics Society in 2004 [52(9):1527-31], the authors concluded that "community physicians appear to underdetect falls and gait disorders, leading to a paucity of recommendations and treatments." Hence the need to revisit the most common gait abnormalities. This multimedia presentation will provide a panorama of bipedalism, from its origin six million years ago in the savannahs of East Africa, to its rise as the unique trait of our species, and eventually to its status as a major cause of disability once full bipedalism is lost. The talk will review the physiology of ambulation and the prevalence of gait disorders in the population. In addition to detailed information on psychogenic and antalgic gaits, participants will learn about the seven major gait abnormalities. Whenever possible, the speaker will enliven the delivery by reviewing "famous patients," or vignettes of historical figures and celebrities who suffered the disorder.


Coffee with Chopra: Episode 6
0.5 CME CREDIT

Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.


FAQ for Cases in Diabetes Management

Guest: Martin J. Abrahamson, MD, FACP

This series of interactive cases will provide an opportunity for the learner to increase their knowledge in the management of people with type 2 diabetes on insulin therapy. The cases will illustrate expert guidelines and general strategies around use of insulin and combinations of injectables for type 2 diabetes, including a practical approach to the initiation and intensification of basal insulin. You will learn the advantages and disadvantages of combination injectable medications as well as how to use them safely and appropriately.